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Recurrent spontaneous abortion (RSA) is a surprisingly
prevalent disorder, affecting an estimated 1 of every 100
couples wishing to have children (Stephenson 1996). The
diagnostic evaluation of RSA is extensive, with many
different etiologies, each causing a small proportion of
the total cases. The etiologies can be grouped into five
categories: anatomic, infectious, hormonal, immuno-
logic, and genetic. The diverse nature of the causal fac-
tors generally obligates a collaborative diagnostic effort,
bringing together gynecologists, reproductive endocri-
nologists, geneticists, and other infertility specialists.De-
spite the thorough (and expensive) diagnostic workup
(Wolf and Horger 1995), it has been estimated that the
specific cause of RSA remains unknown in 37%–79%
of affected women (Hatasaka 1994; Stephenson 1996).
It has been assumed that a large proportion of idio-
pathic RSA is genetic in origin. To date, however, the
standard genetic evaluation consists solely of parental
and abortus karyotyping. This identifies parental defects,
such as balanced translocations, that can cause RSA
(Neri et al. 1983), and it ascertains fetal aneuploidy, a
common cause of spontaneous abortion that intrinsically
has little recurrence risk (Guerneri et al. 1987; Eiben et
al. 1990). As a result, the published total “genetic” con-
tribution to RSA is essentially the frequency of trans-
locations in the cohort of women with RSA: ∼3% (Stray-
Pedersen and Stray-Pedersen 1984; Stephenson 1996).
This is quite likely an underestimation, since subcyto-
genetic defects are almost certainly a significant cause of
RSA.
The hypothesis that either autosomal or X-linked re-
cessive lethal traits could cause RSA is not novel. In fact,
such models are a natural extension of Haldane’s (1935)
publication on mutation selection balance in recessive
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diseases. Identification of recessive lethal traits has been
difficult, since heterozygous carriers of such traits would
appear phenotypically normal. A subset of lethal traits
may cause an increased frequency of spontaneous abor-
tion in carriers if the hemizygous trait produces a clin-
ically detectable pregnancy. Extended pedigrees in which
women exhibit frequent spontaneous abortion are read-
ily available but are difficult to analyze, because of the
high population prevalence of spontaneous abortion and
the assumed extensive genetic and etiologic heteroge-
neity. Although a method for clinically ascertaining car-
riers of autosomal recessive lethal defects remains prob-
lematic, it is possible that carriers of X-linked recessive
lethal traits manifest the molecular phenotype of non-
random (skewed) X chromosome inactivation. The logic
underlying this hypothesis will be illustrated herein.
Nonrandom X Inactivation
The X chromosome is unique in that it undergoes
transcriptional silencing (inactivation) to achieve sex-in-
dependent dosage equilibrium of X-linked genes. X in-
activation occurs early in embryogenesis, at the 64- to
100-cell stage. It is thought to be a stochastic event; that
is, each cell is equally likely to inactivate either the ma-
ternal or paternal allele, and the allele “choice” is not
influenced by neighboring cells. Therefore, in normal
females, approximately half the cells transcribe genes on
the maternal X chromosome.
Given this feature of X chromosome inactivation, it
is unusual to find women with nonrandom (skewed) X
inactivation, that is, the preferential use of either the
paternal or maternal allele in a preponderance of that
female’s cells. When this phenomenon is observed, it is
frequently associated with a defect on one of the X chro-
mosomes. The most extreme example occurs in individ-
uals with X:autosome balanced translocations, in which
the translocated X is found to be active in most cells.
This phenomenon results from improper postzygotic
dosage that is apparently lethal to those cells with the
normal X chromosome active. At the time of X inacti-
vation in such a case, it is presumed that many cells, in
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fact, randomly inactivate the X-chromosome–carrying
autosome-derived material. However, this results in per-
sistent disomic dosage of genes on the portion of the X
chromosome that was translocated to the autosome, in
addition to partial inactivation of autosomal material.
This partial disomic X chromosome dosage and mon-
osomic autosome dosage is deleterious to the cells, caus-
ing cell-autonomous death or growth disadvantage,
yielding highly skewed X inactivation in the female by
the time of birth. It is pertinent to emphasize that the
skewed X inactivation is due to selection against those
cells with improper X dosage and not to a primary defect
in the process of X inactivation (Schmidt and Du Sart
1992).
This model of cell selection during embryonic devel-
opment, which yields skewed X inactivation in an X:
autosome translocation carrier, predicts that functional
hemizygosity for even a single vital X-linked gene would
also lead to skewed X inactivation in a female carrier.
Such a carrier may be spared any clinical phenotype,
but, as a result of selection against those cells missing
the vital gene, she would manifest the molecular phe-
notype of skewed X inactivation. Hemizygous male
progeny of the carrier of such a gene would not be viable
and would spontaneously abort some time after con-
ception. As such, it is possible that female carriers of X-
linked recessive lethal traits will show skewed X inac-
tivation and may show RSA. Since these women would
abort half of all male embryos, their risk of spontaneous
abortion increases from a population risk of 15% to a
combined risk of up to 40% (15% 25%), if we assume
that carriers of X-linked lethal traits do not constitute
a major proportion of all females who experience single
pregnancy losses.
X-Linked Dominant Disorders
The phenotypic expression and familial segregation of
certain disorders solely in females has supported the hy-
pothesis that some diseases are inherited as X-linked
dominant diseases. Implicit in that mode of inheritance
is male lethality, thus explaining the absence of affected
males. For example, incontinentia pigmenti type II (IP2;
MIM 308310), X-linked dominant chondrodysplasia
punctata (MIM 302960) and Rett syndrome (MIM
312750) are strongly suggestive of this type of inheri-
tance. In other disorders, such as fetal akinesia (MIM
300073) and X-linked pterygium (MIM 312150), the
disease phenotype is either clinically similar to autoso-
mal syndromes or is so rare that X-linked lethality can
only be suggested on the basis of a sex bias in the few
observed cases.
The X-inactivation patterns in IP2 and Rett syndrome
yield interesting insights into the possible mechanisms
of male lethality in X-linked dominant disorders. IP2 is
a disease mapped to Xq28 and displays characteristic
skin, retinal, and central nervous system findings. Af-
fected females show highly skewed X inactivation both
in cultured fibroblasts and in peripheral blood, probably
indicating strong selection against those cells expressing
the lethal IP2 allele (Migeon et al. 1989). A report of a
Klinefelter (47, XXY) male with IP2 supports this in-
terpretation; as in XX females, the second X chromo-
some allowed for cell-autonomous selection against mu-
tant alleles (Garcia-Dorado et al. 1990). More recently,
the natural history of a 46, XY pregnancy was described
in which a fetus diagnosed with IP2 by CVS was spon-
taneously aborted at 20 weeks (Devriendt et al. 1998).
It is now proposed that male lethality arises from ab-
sence of a vital gene in hematopoetic or immunologic
development, which is concordant with the finding of
highly skewed X inactivation in the peripheral blood of
carrier females (Roberts et al. 1998). In contrast, in Rett
syndrome, a disorder characterized by severe autism and
purposeless hand movements, skewed X inactivation is
not observed in affected patients (Camus et al. 1996;
Sirianni et al. 1998). Instead, nonpenetrant carriers show
exclusive use of the normal X chromosome and are,
therefore, clinically protected from the disease by the
preferential inactivation of the affected allele (Schanen
et al. 1997; Sirianni et al. 1998). This contrast suggests
that, in Rett syndrome, cells in which the abnormal allele
is expressed survive but cause abnormal brain devel-
opment in the symptomatic carrier; in IP2 patients, on
the other hand, the abnormal allele is lethal to those
cells expressing it. In either case, the mutation likely
confers lethality to the hemizygous male.
Nonrandom X Inactivation as a Mendelian Trait
There is a growing body of literature on the inheri-
tance or familial clustering of skewed X chromosome
inactivation in the absence of any carrier phenotype.
Skewed X inactivation can be classified as either primary
or secondary (Puck and Willard 1998). Primary non-
random X inactivation includes those cases in which
skewed X inactivation is the result of a defect in the
process of X inactivation—that is, either a defect in the
regulation of X inactivation-specific transcript (XIST) or
in another undiscovered gene that mediates X inacti-
vation (Lee and Jaenisch 1997). Conversely, secondary
skewed X inactivation arises because of secondary se-
lection against those cells that have a deleterious mu-
tation on the active X chromosome (Migeon 1998).
Although progress has been made in the functional
characterization of XIST (Penny et al. 1996; Willard
1996; Panning et al. 1997), there are only two reported
familial cases of primary nonrandom X inactivation.
Both of these families carry a CrGmutation in theXIST
minimal promoter, which confers preferential inactiva-
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tion of the X chromosome in cis (Plenge et al. 1997). It
is possible that cases of primary skewed X inactivation
are indeed rare, but the relative scarcity of characterized
cases may also be explained by the fact that XIST en-
codes a structural RNA whose critical sequence features
remain largely unelucidated (Clerc and Avner 1998;
Marahrens et al. 1998). Moreover, the fact that families
segregating such mutations show no clinical phenotype
in either hemizygous males (normal viability) or hetero-
zygous females suggests that primary nonrandom X in-
activation is unlikely to be associated with RSA.
Pegoraro et al. (1997) reported the largest character-
ized family manifesting secondary skewed X inactiva-
tion. In a five-generation family with 50 informative fe-
males, 16 showed highly skewed (95:5) X-chromo-
some inactivation. This family was originally identified
via an apparent manifesting carrier of Duchenne mus-
cular dystrophy (DMD; MIM 310200). However, Pe-
goraro et al. showed that the locus responsible for the
skewed X inactivation molecular phenotype was linked
to a marker at Xq28, rather than to the DMD locus at
Xp21. Subsequently, a relatively large deletion (∼500 kb)
was found in distal Xq28, spanning the region of link-
age. There was complete concordance between deletion
carriers and highly skewed X inactivation. In this large
pedigree, the deletion clearly causes selection against
those cells with the deletion carrying X active. Interest-
ingly, those females carrying the deletion had a statis-
tically significant (P ! .02) increased rate of spontaneous
abortion (40%) compared with their siblings who did
not carry the deletion (15%). This increase in the rate
of spontaneous abortion was due to loss of hemizygous
male embryos that inherited the deletion. This pedigree
represents the first characterized family segregating X-
linked recessive lethality, with females manifesting the
X-linked dominant molecular trait of skewed X inacti-
vation. Both effects are due to the cell-autonomous se-
lection against a lethal trait.
There are several other reports of familial skewed X
inactivation. Naumova et al. (1996) presented a pedigree
in which nonrandom X inactivation appeared to be in-
herited through the paternal line. Moreover, in this fam-
ily the paternal allele conferred preferential inactivation
in trans. Unfortunately, this pedigree was too small to
permit genetic mapping. Recently, Parolini et al. (1998)
reported an 8-year-old manifesting carrier of Wiskott-
Aldrich syndrome with nonrandom X inactivation fa-
voring expression of themutant paternal allele. The girl’s
mother and maternal grandmother also showed non-
random X inactivation, which led the authors to suggest
that there is a primary defect of X inactivation in this
family. However, it is also possible that, as in the family
presented in Pegoraro et al. (1997), this family carries
an X-linked recessive lethal trait in the maternal line,
which causes preferential expression of the paternally
derived disease allele in trans. We propose that such
“trans-manifesting carriers,” in whom the expression of
a recessive disease allele is enforced by cell-autonomous
selection against the other X chromosome, may repre-
sent a significant proportion of the cases of X-linked
recessive disease in females. The mutations responsible
for skewed X inactivation were not identified in either
of the families reported by Naumova et al. (1996) or
Parolini et al. (1998)
The Association between Idiopathic RSA and X Lethal
Loci
If, as we have argued, a subset of female carriers of
X-linked recessive lethal traits are genetically predis-
posed to spontaneous abortion, and if such carriers can
reliably be ascertained via their skewed pattern X chro-
mosome inactivation, it becomes possible to test the hy-
pothesis that X-linked recessive lethal traits are a sig-
nificant cause of RSA in the general population. Intrinsic
to this argument are the assumptions that the trait is cell
autonomous—that is, that it causes death or growth dis-
advantage to the cells with the mutant X active and that
hemizygous males survive at least until the pregnancy is
clinically observable through a positive bHCG test.
To test this hypothesis, we have initiated a case-control
study wherein we compare the frequency of highly
skewed X chromosome inactivation in women with two
or more unexplained spontaneous abortions to the fre-
quency in female controls (Lanasa et al. 1998). The
women characterized with idiopathic RSA have under-
gone a complete evaluation to rule out any of the known
causes of RSA described above (Stephenson 1996). The
controls are women from the same demographic region,
with no known history of spontaneous abortion; fur-
thermore, the cases and controls are age-distribution
matched, so that the distribution of ages between the
two groups is the same. Defining skewed X inactivation
as preferential use of one X chromosome in 90% of
peripheral leukocytes, we have found 7 (14.6%) of 48
to have skewed X inactivation. In contrast, only 1
(1.5%) of 68 control females exhibit this extent of non-
random X inactivation. This finding is statistically sig-
nificant, with P ! .01 (Fisher’s exact test, one-tailed).
The frequency of nonrandom X inactivation is some-
what lower (1.5%) in our control group than has been
reported previously. Other groups have estimated that
the frequency of skewed inactivation (at the level of
90% silencing of one copy of the chromosome) as
3.2% (Gale et al. 1997) or 3.5% (Plenge et al. 1997) in
women of the same age in the population at large. Al-
though case-control comparisons across studies may be
perilous, it is interesting to note that, even when these
higher estimates of skewing frequency are used for the
control group, the frequency we observe in our group
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of RSA-affected women remains significant at the level
of P ! .05 (Fisher’s exact test, one-tailed).
Although the results presented here are clearly prelim-
inary, it is interesting to speculate about the frequency
of X-linked recessive lethal traits in the general popu-
lation. Given a frequency of idiopathic RSA of 1 in 250
in the general population, and an affection rate of ∼1
in 7 in our case population, the population prevalence
of X-linked lethals leading to RSA could be as high as
1 in 1,750. In fact, our ascertainment methodology will
miss a large number of carriers, since, on average, a
carrier would have to become pregnant five times to
show two spontaneous abortions. Furthermore, there is
great selective pressure against such traits. As X-linked
recessive lethal traits can be passed on only to daughters,
the carrier frequency should be halved in each genera-
tion. If 1 in 1,750, in fact, approximates the carrier
frequency, then the new mutation rate must be 1 in
3,500. Since the highest-known single-gene–mutation
rate is that of dystrophin at 1 in 10,000, a mutation rate
of 1 in 3,500 indicates extensive genetic heterogeneity.
This is consistent with the hypothesis that there are a
significant number of vital genes on the X chromosome.
RSA is a major women’s health concern. As the ap-
plication of molecular genetics to RSA advances, it will
be possible to begin characterizing those genes that cause
spontaneous abortion in the recessive state. The X chro-
mosome inactivation assay affords a methodology by
which female carriers of X-linked recessive lethal defects
can be identified. Over time, then, by assembling familial
pedigrees, the individual causative genes can be identi-
fied. The X-inactivation assay should become an im-
portant diagnostic tool in the clinical evaluation of
women with RSA, as secondary skewed X inactivation
will be the common denominator by which carriers of
X-linked recessive lethal traits can be identified.
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